NASDAQ:ADAG

Adagene News Headlines

$13.89
+0.46 (+3.43 %)
(As of 04/13/2021 10:10 AM ET)
Add
Compare
Today's Range
$13.89
Now: $13.89
$13.89
50-Day Range
$14.48
MA: $20.60
$26.32
52-Week Range
$13.05
Now: $13.89
$31.83
Volume30 shs
Average Volume97,641 shs
Market Capitalization$601.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Adagene (NASDAQ ADAG) News Headlines Today

SourceHeadline
Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021
finance.yahoo.com - April 13 at 8:41 AM
Adagene (NASDAQ:ADAG) Trading Down 8.5%Adagene (NASDAQ:ADAG) Trading Down 8.5%
americanbankingnews.com - April 9 at 2:38 PM
Adagene (NASDAQ:ADAG) Shares Gap Down to $17.75Adagene (NASDAQ:ADAG) Shares Gap Down to $17.75
americanbankingnews.com - April 8 at 11:30 AM
Adagene (NASDAQ:ADAG) Hits New 1-Year Low at $16.95Adagene (NASDAQ:ADAG) Hits New 1-Year Low at $16.95
americanbankingnews.com - April 7 at 5:44 PM
Adagene (NASDAQ:ADAG) Sees Large Volume IncreaseAdagene (NASDAQ:ADAG) Sees Large Volume Increase
americanbankingnews.com - March 31 at 11:40 AM
Adagene (NASDAQ:ADAG) Hits New 52-Week Low at $17.00Adagene (NASDAQ:ADAG) Hits New 52-Week Low at $17.00
americanbankingnews.com - March 30 at 5:18 PM
Adagene (NASDAQ:ADAG) Stock Price Up 4.1%Adagene (NASDAQ:ADAG) Stock Price Up 4.1%
americanbankingnews.com - March 29 at 2:37 PM
Adagene Announces Clinical Advancement for ADG116Adagene Announces Clinical Advancement for ADG116
finance.yahoo.com - March 29 at 8:12 AM
Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters Over-Allotment OptionAdagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
feeds.benzinga.com - February 11 at 10:44 AM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.